Abstract
A ureteral stent is widely used to drain ureteral obstructions, which allows urine to bypass the obstruction. The double J stent, a representative ureteral stent, has undergone many advancements in material and design recently. In addition, indications of double J stent insertion have been broadly expanded to improve urinary obstruction before and after extracorporeal shock wave lithotripsy and to maintain ureteral patency after a ureteral surgery or treatment of a ureteral fistula. The recently developed metallic ureteral stents showed excellent long-term patency in patients with malignant ureteral strictures. Therefore, metallic stents could be an alternative to double J stents in select patients. In this review article, we describe the materials, designs, indications, details of the antegrade ureteral stenting procedure, and outcomes of the double J stent and metallic stent procedures.
References
1. Mosayyebi A, Manes C, Carugo D, Somani BK. Advances in ureteral stent design and materials.Curr Urol Rep. 2018; 19:35.
2. Zimskind PD, Fetter TR, Wilkerson JL. Clinical use of longterm indwelling silicone rubber ureteral splints inserted cystoscopically. J Urol. 1967; 97:840–844.
4. Kim JW, Hong B, Shin JH, Park J, Kim JH, Gwon DI, et al. A prospective randomized comparison of a covered metallic ureteral stent and a double-J stent for malignant ureteral obstruction. Korean J Radiol. 2018; 19:606–612.
5. Kim JH, Song K, Jo MK, Park JW. Palliative care of malignant ureteral obstruction with polytetrafluoroethylene membrane-covered self-expandable metallic stents: initial experience.Korean J Urol. 2012; 53:625–631.
6. Chow PM, Chiang IN, Chen CY, Huang KH, Hsu JS, Wang SM, et al. Malignant ureteral obstruction: functional duration of metallic versus polymeric ureteral stents. PLoS One. 2015; 10:e0135566.
7. Asakawa J, Iguchi T, Tamada S, Ninomiya N, Kato M, Yamasaki T, et al. Treatment outcomes of ureteral stenting for malignant extrinsic ureteral obstruction: a comparison between polymeric and metallic stents. Cancer Manag Res. 2018; 10:2977–2982.
8. Dyer RB, Chen MY, Zagoria RJ, Regan JD, Hood CG, Kavanagh PV. Complications of ureteral stent placement. Radiographics. 2002; 22:1005–1022.
9. Al-Aown A, Kyriazis I, Kallidonis P, Kraniotis P, Rigopoulos C, Karnabatidis D, et al. Ureteral stents: new ideas, new designs. Ther Adv Urol. 2010; 2:85–92.
10. Youn SY, Oh JS, Lee HG, Choi BG, Chun HJ, Kim EH. Primary and secondary percutaneous ureteral stent placement: comparison of stent patency and clinical outcome. Cardiovasc Intervent Radiol. 2018; 41:130–136.
11. Patel U, Abubacker MZ. Ureteral stent placement without postprocedural nephrostomy tube: experience in 41 patients. Radiology. 2004; 230:435–442.
12. Watson GM, Patel U. Primary antegrade ureteric stenting: prospective experience and cost-effectiveness analysis in 50 ureters. Cl/iin Radiol. 2001; 56:568–574.
13. Van der Meer RW, Weltings S, Van Erkel AR, Roshani H, Elzevier HW, Van Dijk LC, et al. Antegrade ureteral stenting is a good alternative for the retrograde approach.Curr Urol. 2017; 10:87–91.
14. Chung SY, Stein RJ, Landsittel D, Davies BJ, Cuellar DC, Hrebinko RL, et al. 15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents.J Urol. 2004; 172:592–595.
15. Yossepowitch O, Lifshitz DA, Dekel Y, Gross M, Keidar DM, Neuman M, et al. Predicting the success of retrograde stenting for managing ureteral obstruction.J Urol. 2001; 166:1746–1749.
16. Fine H, Gordon RL, Lebensart PD. Extracorporeal shock wave lithotripsy and stents: fluoroscopic observations and a hypothesis on the mechanisms of stent function. Urol Radiol. 1989; 11:37–41.
17. Watson G. Problems with double-J stents and nephrostomy tubes.J Endourol. 1997; 11:413–417.
18. Saltzman B. Ureteral stents. Indications, variations, and complications.Urol Clin North Am. 1988; 15:481–491.
19. Matsuura H, Arase S, Hori Y. Ureteral stents for malignant extrinsic ureteral obstruction: outcomes and factors predicting stent failure.Int J Clin Oncol. 2019; 24:306–312.
20. Chung HH, Kim MD, Won JY, Won JH, Cho SB, Seo TS, et al. Multicenter experience of the newly designed covered metallic ureteral stent for malignant ureteral occlusion: comparison with double J stent insertion. Cardiovasc Intervent Radiol. 2014; 37:463–470.
21. Lange D, Bidnur S, Hoag N, Chew BH. Ureteral stent-associated complications–where we are and where we are going.Nat Rev Urol. 2015; 12:17–25.
22. Kawahara T, Ito H, Terao H, Yoshida M, Matsuzaki J. Ureteral stent encrustation, incrustation, and coloring: morbidity related to indwelling times.J Endourol. 2012; 26:178–182.
23. Docimo SG, Dewolf WC. High failure rate of indwelling ureteral stents in patients with extrinsic obstruction: experience at 2 institutions. J Urol. 1989; 142:277–279.
24. Bergqvist D, Pärsson H, Sherif A. Arterio-ureteral fistula–a systematic review. Eur J Vasc Endovasc Surg. 2001; 22:191–196.
25. Pillai AK, Anderson ME, Reddick MA, Sutphin PD, Kalva SP. Ureteroarterial fistula: diagnosis and management.A JR Am J Roentgenol. 2015; 204:W592–W598.
26. Muraoka N, Sakai T, Kimura H, Kosaka N, Itoh H, Tanase K, et al. Endovascular treatment for an iliac artery-ureteral fistula with a covered stent. J Vasc Interv Radiol. 2006; 17:1681–1685.
27. Eisner BH, McGovern FJ. Management of ureteroiliac artery fistula.Semin Intervent Radiol. 2007; 24:117–118.
28. Horikawa M, Saito H, Hokotate H, Mori T. Treatment of ureteroarterial fistula with an endoureteral stent graft. J Vasc Interv Radiol. 2012; 23:1241–1243.
29. LeRoy AJ, Williams HJ Jr, Segura JW, Patterson DE, Benson RC Jr. Indwelling ureteral stents: percutaneous management of complications. Radiology. 1986; 158:219–222.
30. Shin JH, Yoon HK, Ko GY, Sung KB, Song HY, Choi E, et al. Percutaneous antegrade removal of double J ureteral stents via a 9-F nephrostomy route. J Vasc Interv Radiol. 2007; 18:1156–1161.
31. Breen DJ, Cowan NC. Fluoroscopically-guided retrieval of ureteric stents.Clin Radiol. 1995; 50:860–863.
32. Yeung EY, Carmody E, Thurston W, Ho CS. Percutaneous fluoroscopically guided removal of dysfunctioning ureteral stents.Radiology. 1994; 190:145–148.
33. Liang HL, Yang TL, Huang JS, Lin YH, Chou CP, Chen MC, et al. Antegrade retrieval of ureteral stents through an 8-French percutaneous nephrostomy route. AJR Am J Roentgenol. 2008; 191:1530–1535.
34. Park SW, Cha IH, Hong SJ, Yi JG, Jeon HJ, Park JH, et al. Fluoroscopy-guided transurethral removal and exchange of ureteral stents in female patients: technical notes. J Vasc Interv Radiol. 2007; 18:251–256.
35. McCarthy E, Kavanagh J, McKernan S, O'Mahony N, McEniff N, Ryan JM, et al. Fluoroscopically guided transurethral removal and/or replacement of ureteric stents in women. Acta Radiol. 2015; 56:635–640.
36. Pedro RN, Hendlin K, Kriedberg C, Monga M. Wire-based ureteral stents: impact on tensile strength and compression. Urology. 2007; 70:1057–1059.
37. Lugmayr HF, Pauer W. Wallstents for the treatment of extrinsic malignant ureteral obstruction: midterm results. Radiology. 1996; 198:105–108.
38. Flueckiger F, Lammer J, Klein GE, Hausegger K, Lederer A, Szolar D, et al. Malignant ureteral obstruction: preliminary results of treatment with metallic self-expandable stents.Radiology. 1993; 186:169–173.
39. Chung KJ, Park BH, Park B, Lee JH, Kim WJ, Baek M, et al. Efficacy and safety of a novel, double-layered, coated, self-expandable metallic mesh stent (UventaTM) in malignant ureteral obstructions.J Endourol. 2013; 27:930–935.